Shire says it will pay $57.5 million to settle with Justice Department
Shire, plc, says it reached an agreement to pay $57.5 million to settle allegations related to its marketing practices that were being investigated by the U.S. Attorney's Office in Philadelphia.
Shire says it will pay $57.5 million to settle with Justice Department
David Sell
Shire P.L.C. has grown from about 100 local workers to around 1,100 since it moved to Wayne in 2004. (TOM GRALISH / Inquirer)
Drugmaker Shire, plc, says it reached an agreement to pay $57.5 million to settle allegations related to its marketing practices that were being investigated by the U.S. Attorney's Office in Philadelphia.
Shire is headquartered in Ireland, but its main office is in suburban Philadelphia.
A spokeswoman for the U.S. Attorney's Office in Philadelphia declined comment.
Comments (0)
Popular Posts
Search this blog:
Blog Roll
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog




